文献速递核素与放射性配体治疗放射性药物与辐射防护

机器人辅助前列腺切除术中基于⁶⁸Ga-PSMA-11的切伦科夫发光成像操作的辐射防护与职业暴露

Radiation Protection and Occupational Exposure on 68Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy.
PubMed 文献 · J Nucl Med · 2021-12-16

本研究纳入10例术前注射⁶⁸Ga-PSMA-11并术中行切伦科夫发光成像(CLI)的机器人辅助根治性前列腺切除术患者,定量描述手术与病理人员的职业辐射暴露。结果显示单次注射⁶⁸Ga-PSMA-11 PET/CT CLI操作在每年不超过110例时职业暴露水平合理,切除前列腺标本放射性活度低于⁶⁸Ga豁免水平。

要点

  • 单次注射⁶⁸Ga-PSMA-11 PET/CT CLI操作在每年不超过110例时职业暴露水平合理。
  • 第一手术助手、洗手护士、CLI成像者/术者的个人等效剂量分别为9.0±7.1、3.3±3.9、0.7±0.7 μSv。
  • 切除前列腺标本的放射性核素含量低于⁶⁸Ga的豁免水平。

核心结论

  • 单次注射⁶⁸Ga-PSMA-11 PET/CT CLI操作在每年不超过110例时职业暴露水平合理。
  • 切除前列腺标本的放射性核素含量低于⁶⁸Ga的豁免水平。

研究设计与样本

  • 研究纳入10例术前接受⁶⁸Ga-PSMA-11给药并术中行CLI的患者。
  • 在PET/CT前(n=10)和PET/CT后(n=5)于1米距离测量4个患者区域(头[A]、右侧[B]、左侧[C]、足[D])的剂量率。
  • 使用电子个人剂量计(EPD)测量术中职业暴露(n=10),涵盖第一手术助手、洗手护士、CLI成像者/术者,覆盖整个手术和CLI图像采集时长。
  • 通过锗探测器测量前列腺标本(n=8)估算病理人员暴露。

主要发现

  • PET/CT前测量的剂量率值为5.3±0.9(平均值±标准差)μSv/h,对应位置B和C的患者特异性剂量率常数为0.047 μSv/h·MBq。
  • PET/CT后平均剂量率值为1.04±1.00 μSv/h,区域A至D对应的患者特异性剂量率常数分别为0.011、0.026、0.024和0.003 μSv/h·MBq。
  • EPD读数显示第一手术助手、洗手护士、CLI成像者/术者的平均个人等效剂量分别为9.0±7.1、3.3±3.9和0.7±0.7 μSv。
  • 锗探测器测得前列腺标本放射性活度中位数为2.96 kBq(四分位距2.23-7.65 kBq)。

临床怎么用

  • 单次注射⁶⁸Ga-PSMA-11 PET/CT CLI操作在每年不超过110例时职业暴露水平合理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cerenkov luminescence imaging (CLI) was successfully implemented in the intraoperative context as a form of radioguided cancer surgery, showing promise in the detection of surgical margins during robot-assisted radical prostatectomy. The present study was designed to provide a quantitative description of the occupational radiation exposure of surgery and histopathology personnel from CLI-guided robot-assisted radical prostatectomy after the injection of 68Ga-PSMA-11 in a single-injection PET/CT CLI protocol. Methods: Ten patients with preoperative 68Ga-PSMA-11 administration and intraoperative CLI were included. Patient dose rate was measured before PET/CT (n = 10) and after PET/CT (n = 5) at a 1-m distance for 4 patient regions (head [A], right side [B], left side [C], and feet [D]). Electronic personal dosimetry (EPD) was used for intraoperative occupational exposure (n = 10). Measurements included the first surgical assistant and scrub nurse at the operating table and the CLI imager/surgeon at the robotic console and encompassed the whole duration of surgery and CLI image acquisition. An estimation of the exposure of histopathology personnel was performed by measuring prostate specimens (n = 8) with a germanium detector. Results: The measured dose rate value before PET/CT was 5.3 ± 0.9 (average ± SD) μSv/h. This value corresponds to a patient-specific dose rate constant for positions B and C of 0.047 μSv/h⋅MBq. The average dose rate value after PET/CT was 1.04 ± 1.00 μSv/h. The patient-specific dose rate constant values corresponding to regions A to D were 0.011, 0.026, 0.024, and 0.003 μSv/h⋅MBq, respectively. EPD readings revealed average personal equivalent doses of 9.0 ± 7.1, 3.3 ± 3.9, and 0.7 ± 0.7 μSv for the first surgical assistant, scrub nurse, and CLI imager/surgeon, respectively. The median germanium detector-measured activity of the prostate specimen was 2.96 kBq (interquartile range, 2.23-7.65 kBq). Conclusion: Single-injection 68Ga-PSMA-11 PET/CT CLI procedures are associated with a reasonable occupational exposure level, if kept under 110 procedures per year. Excised prostate specimen radionuclide content was below the exemption level for 68Ga. Dose rate-based calculations provide a robust estimation for EPD measurements.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Costa PF, Fendler WP, Herrmann K, et al. Radiation Protection and Occupational Exposure on 68Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy. J Nucl Med. 2021. PMID: 34916249. doi:10.2967/jnumed.121.263175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。